• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Matthew S. Davids, MD


  • Brown JR, Messmer BT, Werner L, Davids MS, Mikler E, Supko JG, Fisher DC, Lacasce AS, Armand P, Jacobsen E, Dalton V, Tesar B, Fernandes SM, McDonough S, Ritz J, Rassenti L, Kipps TJ, Neuberg D, Freedman AS.A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia / small lymphocytic lymphoma.Haematologica. 2013 May 3.
  • Davids MS, Letai A, Brown JR.Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition.Leuk Lymphoma. 2013 Apr 25.
  • Davids MS, Brown JR.Phosphoinositide 3'-kinase inhibition in chronic lymphocytic leukemia.Hematol Oncol Clin North Am. 2013 Apr;27(2):329-39.
  • Davids MS, Letai A.ABT-199: taking dead aim at BCL-2.Cancer Cell. 2013 Feb 11;23(2):139-41.
  • Armand P, Welch S, Kim HT, LaCasce AS, Jacobsen ED, Davids MS, Jacobson C, Fisher DC, Brown JR, Coughlin E, Freedman AS, Chen YB.Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era.British Journal of Haematology. 2013 Mar;160(5):608-17.
  • Davids MS, Deng J, Wiestner A, Lannutti BJ, Wang L, Wu CJ, Wilson WH, Brown JR, Letai A.Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.Blood. 2012 Oct 25;120(17):3501-9.
  • Dutta C, Day T, Kopp N, van Bodegom D, Davids MS, Ryan J, Bird L, Kommajosyula N, Weigert O, Yoda A, Fung H, Brown JR, Shapiro GI, Letai A, Weinstock DM.BCL2 suppresses PARP1 function and nonapoptotic cell death.Cancer Res. 2012 Aug 15;72(16):4193-203.
  • Davids MS, Burger JA.Cell Trafficking in Chronic Lymphocytic Leukemia.Open J Hematol. 2012;3(S1).
  • Comen E, Davids M, Kirchhoff T, Hudis C, Offit K, Robson M.Relative contributions of BRCA1 and BRCA2 mutations to "triple-negative" breast cancer in Ashkenazi Women.Breast Cancer Res Treat. 2011 Mar 11.
  • Davids MS, Steensma DP.The molecular pathogenesis of myelodysplastic syndromes.Cancer Biol Ther. 2010 Aug;10(4):309-19.
  • Davids MS, Murali MR, Kuter DJ.Serum free light chain analysis.Am J Hematol. 2010 Oct;85(10):787-90. Review.
  • Davids MS, Case C, Hornung R, Chao NJ, Chute JP, Coleman CN, Weisdorf D, Confer DL, Weinstock DM.Assessing surge capacity for radiation victims with marrow toxicity.Biol Blood Marrow Transplant. 2010 Oct;16(10):1436-41.
  • Davids MS, Case C, Confer DL, Weisdorf DJ, Weinstock DM.Medical management of radiation victims in the United States.Health Phys. 2010 Jun;98(6):833-7.
  • Davids MS, Davids M, Charlton A, Ng SS, Chong ML, Laubscher K, Dar M, Hodge J, Soong R, Goh BC.Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma.J Clin Oncol. 2009 Sep 10;27(26):e97-100.
  • Davids MS, Crawford E, Weremowicz S, Morton CC, Copeland NG, Gilbert DJ, Jenkins NA, Phelan MC, Comb MJ, Melnick MB.STK25 is a candidate gene for pseudopseudohypoparathyroidism.Genomics. 2001 Sep;77(1-2):2-4.